诊断学理论与实践 ›› 2025, Vol. 24 ›› Issue (01): 14-20.doi: 10.16150/j.1671-2870.2025.01.003
邹慧敏, 王遂军
收稿日期:
2024-11-15
接受日期:
2025-02-09
出版日期:
2025-02-25
发布日期:
2025-02-25
ZOU Huimin, WANG Suijun
Received:
2024-11-15
Accepted:
2025-02-09
Published:
2025-02-25
Online:
2025-02-25
摘要:
我国糖尿病患病率逐年攀升,2021年我国20~79岁人群中糖尿病患病率高达13.79%,未确诊率高达56.0%,显示我国的糖尿病防控工作正面临严峻挑战。糖尿病是一种慢性代谢性疾病,患者血糖控制不佳容易出现严重的并发症风险,如心血管疾病、肾脏疾病、视网膜病变、神经病变等,对个人健康和社会经济造成沉重负担。及早发现糖尿病并采取有效干预措施,对预防并发症至关重要。目前,我国糖尿病诊断主要参考国外标准,以75 g口服葡萄糖耐量试验(oral glucose tolerance test,OGTT)和糖化血红蛋白(glycated hemoglobin,HbA1c)作为诊断金标准。然而,由于检测技术的差异等问题,这些方法在临床实践中仍存在一定的局限性,尤其是在基层医疗机构中,糖尿病筛查能力及同质化水平有待进一步提高。此外,我国糖尿病的知晓率、治疗率和控制率均处于较低水平,2021年数据显示,我国糖尿病患者知晓率为36.5%,治疗率为33.2%,控制率为49.2%。尽管近年来我国在糖尿病防治方面取得了一定进展,但仍存在较大的提升空间。为应对糖尿病防控的挑战,国内专家发布了一系列糖尿病指南及专家共识,强调对糖尿病患者管理的个体化和分层管理,针对儿童青少年、妊娠期妇女和老年患者,制定了不同的血糖控制目标及治疗方案。同时,强化血糖监测技术的应用推广也被视为提升血糖控制达标率的重要手段。然而,目前临床对儿童青少年2型糖尿病、妊娠期糖尿病及老年糖尿病合并肌少症患者的关注度仍显不足,缺乏规范的治疗策略和高质量的循证医学证据。针对我国糖尿病诊疗现状,仍需进一步提升疾病的检验水平、检查覆盖率及不同人群分类管理能力。
中图分类号:
邹慧敏, 王遂军. 中国糖尿病诊断标准演变及特殊人群血糖管理[J]. 诊断学理论与实践, 2025, 24(01): 14-20.
ZOU Huimin, WANG Suijun. Evolution of diagnosis standards for diabetes in China and blood glucose management for special populations[J]. Journal of Diagnostics Concepts & Practice, 2025, 24(01): 14-20.
[1] | 中国疾病预防控制中心, 中国疾病预防控制中心慢性非传染性疾病预防控制中心. 中国慢性病及危险因素监测报告2018[M]. 北京:人民卫生出版社,2021. |
Chinese Center for Disease Control and Prevention, Chronic Non communicable Disease Prevention and Control Center of Chinese Center for Disease Control and Prevention. Report on chronic disease risk factor surveillance in China, 2018[M]. Beijing:People's Medical Publishing House,2021. | |
[2] | SUN H, SAEEDI P, KARURANGA S, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract,2022,183:109119. |
[3] | 钟学礼. 全国14省市30万人口中糖尿病调查报告[J]. 中华内科杂志,1981,20(11):678-683. |
ZHONG X L. Investigation report on diabetes among 300 thousand population in 14 provinces and cities in China[J]. Chin J Intern Med,1981,20(11):678-683. | |
[4] | WANG L, PENG W, ZHAO Z, et al. Prevalence and Treatment of Diabetes in China, 2013-2018[J]. JAMA,2021,326(24):2498-2506. |
[5] | International Diabetes Federation. IDF diabetes atlas 2021 (10th edition)[M]. Brussels: International Diabetes Federation,2021. |
[6] | American Diabetes Association Professional Practice Committee. Diagnosis and classification of diabetes: standards of care in diabetes-2024[J]. Diabetes Care,2024,47():S20-S42. |
[7] | Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation[R]. Geneva: World Health Organization,2011. |
[8] | MEIJNIKMAN A S, DE BLOCK C E M, DIRINCK E, et al. Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population[J]. Int J Obes (Lond),2017,41(11):1615-1620. |
[9] | SACKS D B, ARNOLD M, BAKRIS G L, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus[J]. Diabetes Care,2023,46(10):e151-e199. |
[10] | ZHANG X, GREGG E W, WILLIAMSON D F, et al. A1C level and future risk of diabetes: a systematic review[J]. Diabetes Care,2010,33(7):1665-1673. |
[11] | SELVIN E, STEFFES M W, ZHU H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults[J]. N Engl J Med,2010,362(9):800-811. |
[12] | LIN L, WANG A, HE Y, et al. Effects of the hemoglobin glycation index on hyperglycemia diagnosis: Results from the REACTION study[J]. Diabetes Res Clin Pract,2021,180:109039. |
[13] | GALLAGHER E J, LE ROITH D, BLOOMGARDEN Z. Review of hemoglobin A(1c) in the management of diabetes[J]. J Diabetes,2009,1(1):9-17. |
[14] | BECK R W, BERGENSTAL R M, RIDDLESWORTH T D, et al. Validation of time in range as an outcome measure for diabetes clinical trials[J]. Diabetes Care,2019,42(3):400-405. |
[15] | LU J, MA X, ZHOU J, et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes[J]. Diabetes Care,2018,41(11):2370-2376. |
[16] | LU J, MA X, SHEN Y, et al. Time in range is associated with carotid intima-media thickness in type 2 diabetes[J]. Diabetes Technol Ther,2020,22(2):72-78. |
[17] | ZHAO W, LU J, ZHANG L, et al. Relationship between time in range and corneal nerve fiber loss in asymptomatic patients with type 2 diabetes[J]. Chin Med J (Engl),2022,135(16):1978-1985. |
[18] | KRISTENSEN K, ÖGGE L E, SENGPIEL V, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies[J]. Diabetologia,2019,62(7):1143-1153. |
[19] | DANNE T, NIMRI R, BATTELINO T, et al. International consensus on use of continuous glucose monitoring[J]. Diabetes Care,2017,40(12):1631-1640. |
[20] | 蔡玉立, 易波, 陈小琳, 等. 动态血糖监测技术与临床研究进展[J]. 中国糖尿病杂志,2021,29(12):933-940. |
CAI Y L, YI B, CHEN X L, et al. Progress of continuous glucose monitoring technology and clinical researches[J]. Chin J Diaetes,2021,29(12):933-940. | |
[21] | WU W, ZHANG J W, LI Y, et al. Population-based prevalence of self-reported pediatric diabetes and screening for undiagnosed type 2 diabetes in Chinese children in years 2017-2019, a cross-sectional study[J]. Lancet Reg Health West Pac,2024,52:101206. |
[22] | SHAH A S, ZEITLER P S, WONG J, et al. ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 diabetes in children and adolescents[J]. Pediatr Diabetes,2022,23(7):872-902. |
[23] | 中华医学会儿科学分会内分泌遗传代谢学组,中国医师协会青春期健康与医学专业委员会. 儿童2型糖尿病诊治指南(2025)[J]. 中华儿科杂志,2025,63(2):131-137. |
The Subspecialty Group of Endocrinology, Hereditary and Metabolic Diseases, the Society of Pediatrics, Chinese Medical Association, Adolescent Health and Medical Professional Committee, Chinese Medical Doctor Association. Guidelines for the diagnosis and treatment of type 2 diabetes mellitus in children (2025)[J]. Chin J Pediatr,2025,63(2):131-137. | |
[24] | GUNGOR N, BACHA F, SAAD R, et al. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both?[J]. Diabetes Care,2005,28(3):638-644. |
[25] | VANDORSTEN J P, DODSON W C, ESPELAND M A, et al. NIH consensus development conference: diagnosing gestational diabetes mellitus[J]. NIH Consens State Sci Statements,2013,29(1):1-31. |
[26] | 中华医学会糖尿病学分会. 中国糖尿病防治指南(2024 版)[J]. 中华糖尿病杂志, 2025, 17(1): 16-139. |
Chinese Diabetes Society. Guideline for the prevention and treatment of diabetes mellitus in China (2024 edition)[J]. Chin J Diab Mellitus,2025,17(1):16-139. | |
[27] | 《儿童肥胖预防与控制指南》修订委员会. 儿童肥胖预防与控制指南(2021)[M]. 北京: 人民卫生出版社, 2021. |
Revision Committee for Guidelines for Prevention and Control of Childhood Obesity. Guidelines for prevention and control of childhood obesity (2021)[M]. Beijing:People's Medical Publishing House,2021. | |
[28] | ARSLANIAN S, BACHA F, GREY M, et al. Evaluation and management of youth-onset type 2 diabetes: a position statement by the American Diabetes Association[J]. Diabetes Care,2018,41(12):2648-2668. |
[29] | TODAY Study Group. Safety and tolerability of the treatment of youth-onset type 2 diabetes: the TODAY experience[J]. Diabetes Care,2013,36(6):1765-1771. |
[30] | U. S. Food and Drug Administration. FDA approves new treatment for pediatric patients with type 2 diabetes[EB/OL]. 2024. https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-pediatric-patients-type-2-diabetes. |
[31] | 王金涛, 胡坚. 老年人2型糖尿病与肌少症的关系研究进展[J]. 实用老年医学,2024,38(5):529-532. |
WANG J T, HU J. Research progress on the relationship between type 2 diabetes and myopenia in the elderly[J]. Pract Geriatr,2024,38(5):529-532. | |
[32] | WANG T, FENG X, ZHOU J, et al. Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly[J]. Sci Rep,2016,6:38937. |
[33] | YOON J W, HA Y C, KIM K M, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean longitudinal study on health and aging[J]. Diabetes Metab J,2016,40(2):140-146. |
[34] | 张宁, 刘晓红, 康琳, 等. 肌少症对住院老年2型糖尿病患者远期预后的影响:前瞻性队列研究[J]. 协和医学杂志,2024,15(6):1348-1355. |
ZHANG N, LIU X H, KANG L, et al. Impact of Sarcopenia on long-term outcomes in elderly inpatients with type 2 diabetes mellitus:a prospective cohort study[J]. Med J Peking Union Med College Hosp,2024,15(6):1348-1355. | |
[35] | RAHI B, MORAIS J A, GAUDREAU P, PAYETTE H, et al. Energy and protein intakes and their association with a decline in functional capacity among diabetic older adults from the NuAge cohort[J]. Eur J Nutr,2016,55(4):1729-1739. |
[36] | DEN KAMP C M OP, LANGEN R C, HAEGENS A, et al. Muscle atrophy in cachexia: can dietary protein tip the balance?[J]. Curr Opin Clin Nutr Metab Care,2009,12(6):611-616. |
[37] | SHUKLA A P, DICKISON M, COUGHLIN N, et al. The impact of food order on postprandial glycaemic excursions in prediabetes[J]. Diabetes Obes Metab,2019,21(2):377-381. |
[38] | TAN S, LI W, WANG J. Effects of six months of combined aerobic and resistance training for elderly patients with a long history of type 2 diabetes[J]. J Sports Sci Med,2012,11(3):495-501. |
[39] | LU X, ZHAO C. Exercise and type 1 diabetes[J]. Adv Exp Med Biol,2020,1228:107-121. |
[40] | CHEN F, XU S, WANG Y, et al. Risk factors for sarcopenia in the elderly with type 2 diabetes mellitus and the effect of metformin[J]. J Diabetes Res,2020,2020:3950404. |
[41] | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志,2021,13(4):315-409. |
Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)[J]. Chin J Diabetes Mellitus,2021,13(4):315-409. | |
[42] | ACOG practice bulletin No. 190: gestational diabetes mellitus[J]. Obstet Gynecol,2018,131(2):e49-e64. |
[43] | 中国研究型医院学会糖尿病学专业委员会, 肖新华. 中国妊娠期糖尿病母儿共同管理指南(2024版)[J]. 中国研究型医院,2024,11(6):11-31. |
Diabetology Committee of Chinese Research Hospital Association, XIAO X H. Guidelines for the co-management of gestational diabetes mellitus in mothers and their offspring (2024 edition)[J]. Chin Res Hosp,2024,11(6):11-31. | |
[44] | American Diabetes Association Professional Practice Committee. 15. Management of diabetes in pregnancy: standards of care in diabetes-2024[J]. Diabetes Care,2024,47():S282-S294. |
[45] | ZHU W W, YANG H X, WEI Y M, et al. Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in china[J]. Diabetes Care,2013,36(3):586-590. |
[46] | MAÑÉ L, FLORES-LE ROUX J A, GÓMEZ N, et al. Association of first-trimester HbA1c levels with adverse pregnancy outcomes in different ethnic groups[J]. Diabetes Res Clin Pract,2019,150:202-210. |
[47] | 姚雅鸿, 李丽, 方园, 等. 妊娠期糖尿病产后随访管理研究进展[J]. 中国糖尿病杂志,2022,30(6):466-469. |
YAO Y H, LI L, FANG Y, et al. The research progress on postpartum follow-up management of gestational diabetes mellitus[J]. Chin J Diabetes Mellitus,2022,30(6):466-469. |
[1] | 宁光. 中国糖尿病的防控现状与挑战[J]. 诊断学理论与实践, 2025, 24(01): 1-6. |
[2] | 张珂, 张唯一, 孙海天, 曹铭峰, 张新焕. 细胞失巢相关基因PDK4与2型糖尿病发病相关——基于生物信息的研究[J]. 诊断学理论与实践, 2025, 24(01): 27-34. |
[3] | 雷朝闻尉, 饶佳玲, 周梦雪, 杨虹. 胰腺脂肪沉积的危险因素及相关疾病的研究进展[J]. 诊断学理论与实践, 2025, 24(01): 72-79. |
[4] | 何翠环, 石德荣, 孙丹丹, 李育蕊, 夏广昊. 胰高血糖素样肽1受体激动剂在糖尿病视网膜病变中的作用机制研究进展[J]. 诊断学理论与实践, 2025, 24(01): 80-88. |
[5] | 裴舟, 罗飞宏. 中国儿童糖尿病诊治进展[J]. 诊断学理论与实践, 2024, 23(05): 461-466. |
[6] | 李延兵. 2024年美国糖尿病学会《糖尿病诊疗标准》解读——糖尿病诊断和分型[J]. 诊断学理论与实践, 2024, 23(05): 467-473. |
[7] | 缪婕, 王巍, 赵雅洁, 张凤如, 沈琳辉. 老年男性2型糖尿病患者游离三碘甲状腺原氨酸水平与左心室舒张功能不全相关[J]. 诊断学理论与实践, 2024, 23(02): 155-161. |
[8] | 周思锋, 朱洁云, 徐海舒, 倪瑛. 色素上皮衍生因子在糖尿病视网膜病变中的作用机制研究进展[J]. 诊断学理论与实践, 2024, 23(02): 192-201. |
[9] | 张琼, 吴彦霖, 胡起维, 张泽伟, 黄守约. 光学相干断层扫描血管成像参数诊断非增殖性糖尿病视网膜病变的价值分析[J]. 诊断学理论与实践, 2024, 23(01): 67-76. |
[10] | 中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下糖尿病管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 136-138. |
[11] | 陈煦阳, 顾卫琼. 胰岛素自身抗体临床检测应用局限及对策研究进展[J]. 诊断学理论与实践, 2022, 21(01): 95-98. |
[12] | 王广宇, 杨昕, 张立娟, 谭姣容. 住院新诊断2型糖尿病男性患者血浆总睾酮水平与骨钙素的相关性研究[J]. 诊断学理论与实践, 2021, 20(06): 573-578. |
[13] | 章淼滢, 罗飞宏. 儿童单基因糖尿病诊治进展及诊断策略[J]. 诊断学理论与实践, 2021, 20(03): 229-232. |
[14] | 范秋灵. 糖尿病肾病和非糖尿病慢性肾脏病患者应用钠-葡萄糖协同转运蛋白2抑制剂:预后评估及相关指南解读[J]. 诊断学理论与实践, 2021, 20(02): 130-137. |
[15] | 赵红燕, 刘建民. 2019年《糖尿病患者骨折风险管理中国专家共识》解读[J]. 诊断学理论与实践, 2020, 19(03): 225-228. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||